Prognostic Impact of Urokinase Plasminogen Activator Receptor Expression in Pancreatic Cancer: Malignant Versus Stromal Cells

The urokinase plasminogen activator receptor (uPAR) has been proposed as a potential prognostic factor for various malignancies. The aim of this study is to assess the prognostic value of uPAR expression in neoplastic and stromal cells of patients with pancreatic adenocarcinoma. Urokinase plasminoge...

Descripción completa

Detalles Bibliográficos
Autores principales: de Geus, Susanna WL, Baart, Victor M, Boonstra, Martin C, Kuppen, Peter JK, Prevoo, Hendrica AJM, Mazar, Andrew P, Bonsing, Bert A, Morreau, Hans, van de Velde, Cornelis JH, Vahrmeijer, Alexander L, Sier, Cornelis FM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484551/
https://www.ncbi.nlm.nih.gov/pubmed/28690396
http://dx.doi.org/10.1177/1177271917715443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484551/
https://www.ncbi.nlm.nih.gov/pubmed/28690396
http://dx.doi.org/10.1177/1177271917715443

Ejemplares similares